Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
ImmunoPrecise Antibodies (IPA)
NASDAQ:IPA
RESEARCH TOOLSreports
Holding IPA?
Track your performance easily
ImmunoPrecise Antibodies (IPA) Ownership Overview
1.20% Insiders
0.06% Mutual Funds
5.88% Other Institutional Investors
92.85% Public Companies and
Individual Investors
The ownership structure of ImmunoPrecise Antibodies (IPA) stock is a mix of institutional, retail, and individual investors. , 1.20% is owned by Insiders, and 92.85% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Aug 03, 2024 | Jennifer Lynne Bath President & Chief Executive Officer | xxxxxxxxxxxxx | $10008 |
| Aug 03, 2024 | Barry Alan Springer Non Executive,director | xxxxxxxxxxxxx | $4350 |
| Aug 02, 2024 | Kristin Taylor Chief Financial Officer | xxxxxxxxxxxxx | $8200 |
| Aug 02, 2024 | Mitch Levine Chairman,director | xxxxxxxxxxxxx | $8156 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 260,818 | Insider | 0.93% | 99,632 | |
| 30,000 | Insider | 0.11% | 11,460 | |
| 20,000 | Insider | 0.07% | 7,640 | |
| 17,484 | Institution | 0.06% | 6,679 | |
| 15,000 | Insider | 0.05% | 5,730 | |
| 9,542 | Insider | 0.03% | 3,645 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 17,484 | Institution | 0.06% | 6,679 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|
FAQ
Who Owns ImmunoPrecise Antibodies (IPA)?
According to the latest TipRanks data, approximately 5.88% of the company's stock is held by institutional investors, 1.20% is held by insiders, and 92.85% is held by retail investors.
What percentage of ImmunoPrecise Antibodies (IPA) stock is held by institutional investors?
According to the latest TipRanks data, approximately 5.88% of ImmunoPrecise Antibodies (IPA) stock is held by institutional investors.
What percentage of ImmunoPrecise Antibodies (IPA) stock is held by retail investors?
According to the latest TipRanks data, approximately 92.85% of ImmunoPrecise Antibodies (IPA) stock is held by retail investors.
Who owns the most shares of ImmunoPrecise Antibodies (IPA)?
Jennifer Lynne Bath owns the most shares of ImmunoPrecise Antibodies (IPA).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.